Bromide

Bromide

SCHEMBL1548089

C=CC(CCCCCCCCCCC)[n+]1ccccc1.[Br-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 2/20 0.43
CHRM1 known ✓ P11229 2/20 0.43
ACHE known ✓ P22303 2/20 0.43
CHRM4 known ✓ P08173 1/20 0.43
CHRM5 known ✓ P08912 1/20 0.43
CHRM3 known ✓ P20309 1/20 0.43
OPRM1 known ✓ P35372 1/20 0.40
RAD52 P43351 3/20 0.43
HSP90AA1 P07900 2/20 0.43
ADRA2A P08913 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.43
EGFR P00533 1/20 0.43
LMNA P02545 1/20 0.43
PLA2G1B P04054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557911 0.96 CHRM2 (0.38) RAD52HSP90AA1CHRM2ADRA2AADORA3
SCHEMBL18035807 0.91 CHRM2 (0.35) RAD52HSP90AA1CHRM2ADRA2AADORA3
Hydrochloric Acid SCHEMBL3479352 0.89 KMT2A (0.37) RAD52HSP90AA1CHRM2ADRA2AADORA3
Bromide SCHEMBL9299877 0.85 HSP90AA1 (0.31) RAD52HSP90AA1CHRM2ADRA2AADORA3
Iodide SCHEMBL11381556 0.82
Acetic Acid SCHEMBL15210170 0.81 CA2 (0.34) ACHETSHRMAPK1
SCHEMBL16650419 0.75
Bromide SCHEMBL28419938 0.74 RAD52 (0.48) RAD52HSP90AA1CHRM2ADRA2AADORA3
Bromide SCHEMBL28845552 0.74 RAD52 (0.48) RAD52HSP90AA1CHRM2ADRA2AADORA3
Bromide SCHEMBL28057294 0.74 RAD52 (0.48) RAD52HSP90AA1CHRM2ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4144416-A1 FOAMING SUNSCREEN COMPOSITION CONTAINING AN ULTRAVIOLET RADIATION-ABSORBING COMPOUND AND A SUPERHYDROPHILIC AMPHIPHILIC COPOLYMER Johnson & Johnson Consumer Inc. (US) 2023-03-08 EP disclosed
EP-3349723-B1 SUNSCREEN COMPOSITIONS COMPRISING SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS JOHNSON & JOHNSON CONSUMER INC (US) 2022-03-16 EP disclosed
EP-3349863-B1 FOAMING SUNSCREEN COMPOSITION CONTAINING AN ULTRAVIOLET RADIATION-ABSORBING COMPOUND AND A SUPERHYDROPHILIC AMPHIPHILIC COPOLYMER JOHNSON & JOHNSON CONSUMER INC (US) 2022-01-19 EP disclosed
US-11173106-B2 Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener JOHNSON & JOHNSON CONSUMER INC. (US) 2021-11-16 US disclosed
EP-3349723-A1 SUNSCREEN COMPOSITIONS COMPRISING SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS Johnson & Johnson Consumer Inc. (US) 2018-07-25 EP disclosed
EP-3349863-A1 FOAMING SUNSCREEN COMPOSITION CONTAINING AN ULTRAVIOLET RADIATION-ABSORBING COMPOUND AND A SUPERHYDROPHILIC AMPHIPHILIC COPOLYMER Johnson & Johnson Consumer Inc. (US) 2018-07-25 EP disclosed
EP-2486063-B1 SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS AND PROCESSES FOR MAKING THE SAME AKZO NOBEL CHEMICALS INT BV (NL) 2018-03-28 EP disclosed
EP-2024476-B1 COMPOSITIONS COMPRISING LOW-DP POLYMERIZED SURFACTANTS AND METHODS OF USE THEREOF JOHNSON & JOHNSON CONSUMER INC (US) 2017-11-15 EP disclosed
EP-2021448-B1 COMPOSITIONS COMPRISING LOW-DP POLYMERIZED SURFACTANTS AND METHODS OF USE THEREOF JOHNSON & JOHNSON CONSUMER INC (US) 2017-09-13 EP disclosed
EP-2021447-B1 COMPOSITIONS COMPRISING LOW-DP POLYMERIZED SURFACTANTS AND METHODS OF USE THEREOF JOHNSON & JOHNSON CONSUMER INC (US) 2017-09-13 EP disclosed
EP-2021447-A1 COMPOSITIONS COMPRISING LOW-DP POLYMERIZED SURFACTANTS AND METHODS OF USE THEREOF JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2009-02-11 EP disclosed
US-7446087-B2 Compositions comprising low-DP polymerized surfactants and methods of use thereof JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2008-11-04 US disclosed
US-7446088-B2 Compositions comprising low-DP polymerized surfactants and methods of use thereof JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2008-11-04 US disclosed
US-7417020-B2 low-irritation; for treating the skin, hair, or vaginal region JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2008-08-26 US disclosed
WO-2007130237-A2 COMPOSITIONS COMPRISING LOW-DP POLYMERIZED SURFACTANTS AND METHODS OF USE THEREOF JOHNSON & JOHNSON CONSUMER, COMPANIES, INC. (US) 2007-11-15 WO disclosed
WO-2007130236-A2 COMPOSITIONS COMPRISING LOW-DP POLYMERIZED SURFACTANTS AND METHODS OF USE THEREOF JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2007-11-15 WO disclosed
WO-2007130238-A1 COMPOSITIONS COMPRISING LOW-DP POLYMERIZED SURFACTANTS AND METHODS OF USE THEREOF JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2007-11-15 WO disclosed
US-20070259797-A1 Compositions comprising low-DP polymerized surfactants and methods of use thereof JOHNSON & JOHNSON CONSUMER INC. 2007-11-08 US disclosed
US-20070259798-A1 Compositions comprising low-DP polymerized surfactants and methods of use thereof JOHNSON & JOHNSON CONSUMER INC. 2007-11-08 US disclosed
US-20070259796-A1 Compositions comprising low-DP polymerized surfactants and methods of use thereof JOHNSON & JOHNSON CONSUMER INC. 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259796-A1 Compositions comprising low-DP polymerized surfactants and methods of use thereof DSG1, DSP, CUTA CHRM2 3471/4885CHRM1 3645/4885ACHE 968/4885
US-20070259797-A1 Compositions comprising low-DP polymerized surfactants and methods of use thereof DSG1, DSP, CUTA CHRM2 3471/4885CHRM1 3645/4885ACHE 968/4885
US-20070259798-A1 Compositions comprising low-DP polymerized surfactants and methods of use thereof DSG1, DSP, CUTA CHRM2 3471/4885CHRM1 3645/4885ACHE 968/4885
US-11173106-B2 Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener ABHD16A, DSG1, CUTA CHRM2 2479/4885CHRM1 2675/4885ACHE 820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.